Science sees future beyond Paralympics

March 6, 2014 by Mariette Le Roux
Tentative but encouraging signs are emerging in the quest for restoring function to paralysed limbs—one promising innovation involves replacing or reinvigorating damaged central nervous system cells using stem cells

Imagine a future with no sporting events for paralysed people. A future in which there is no need, as all the would-be competitors will have been cured.

This scenario, laughable just a few decades ago, is no longer far-fetched, experts say.

Bit by bit, important progress is being made in understanding and tackling aspects of .

Some believe the time is fast approaching when the major secondary problems from paralysis—bowel, bladder and sexual dysfunction, breathing complications, declining muscle tone and bone density—will be treatable, probably through a combination of drugs, cell replacement, physical training and electronic aids.

And tentative but encouraging signs are emerging in the quest for the ultimate goal: restoring function to paralysed limbs.

"This is an enormously complicated, but we do believe solvable, problem," said Susan Howley, vice-president of research at the New Jersey-based Christopher and Dana Reeve Foundation for paralysis.

"Some of the best and brightest people at work in the neurosciences are thinking about spinal cord injury repair, and working on it. There is tremendous hope," she told AFP.

Paralysis, full or partial, happens when a message from the brain gets lost on its way to the muscles, blocked by illness or damage to the spinal highway.

As recently as 20 years ago, researchers focused not on a cure, but simply on making the person comfortable.

"There was a belief that you are born with a certain number of neurons and when they die, they die, the dogma was that you cannot repair" the damage, said Mark Bacon, research director at Spinal Research, a UK charity.

That thinking has been swept away, although the available options remain unchanged: the only licensed treatment is physical rehabilitation, which is useful but limited.

In the lab, though, extraordinary experiments are taking place.

These include cell replacement and regeneration, spinal scar-tissue removal, electric muscle stimulation and brain-computer connections.

Some are in clinical trials—the long process of vetting a new drug or medical technique for safety and efficacy.

Hopeful of a breakthrough

One promising innovation involves replacing or reinvigorating dead or damaged central nervous system cells using , including cells controversially harvested from embryos.

"We are hopeful of a breakthrough," said Martin McGlynn, president of Newark-based StemCells Inc, which implants human directly into the spines of paralysed trial patients.

"(...) [T]his therapy has the potential to provide a long-lasting benefit with the potential to also significantly reduce the overall health care burden."

Though promising, observers like Howley point out that , like most other therapies, is in its infancy.

"We need to better understand which are the best cells to be transplanted and which kind of stem cell should be optimally used; how well do the transplanted cells actually integrate into the central nervous system and become functioning; and how to contend with the scar at the lesion site," she said.

The last three years have also seen exciting developments in electrical spinal stimulation.

The work bypasses attempts to link the brain to muscles, instead using electrodes to jolt the relatively autonomous nerve networks of the lower spine directly.

Some experiments have shown paralysed people stand on their own two feet and regain limited movement, though apparently no feeling.

Some individuals regained varying degrees of bladder control and sexual function—"a patient population for whom it was always believed that nothing could be done", Howley noted.

Among the most thrilling work, though expensive and invasive, is in brain-computer interfaces—using electrodes to read the intent of the brain to make a movement and relaying that message to muscles to enact it.

"The brain-machine interface is a promising field, but we are taking the first, faltering steps," said Nathanael Jarrasse, a robot specialist at the French National Centre for Scientific Research (CNRS).

A common and tragic problem

As many as 500,000 people per year suffer —one of the main causes of paralysis, according to the World Health Organisation (WHO).

What are the chances of a cure?

"It's obvious there isn't going to be a single magic bullet," said Howley.

"The way we have to think about fixing spinal cord injury is picking the low-hanging fruit first, as we continue to work towards fixing the more difficult, long-term problems."

Experts believe the answer will be a combination of treatments.

Doctors would likely administer a "neuroprotectant" drug as soon as possible after injury to reduce the death of precious nerve cells, said Bacon.

This could be followed by a drug to encourage the rerouting of broken nerve connections. Next could be cell replacement therapy to reverse whatever damage could not be stopped.

Finally, the patient may be helped with electrical stimulation to restore some automatic functions and computer-brain interfaces to wield a still useless limb.

"We are at the beginning of the journey in the same way cancer was 20 or 30 years ago, where we have the prospects of treatments that will improve the outcome, and with time we will refine those," said Bacon.

Explore further: Evidence for spinal membrane as a source of stem cells may advance spinal cord treatment

Related Stories

Stem cell scarring aids recovery from spinal cord injury

October 31, 2013

In a new study, researchers at Karolinska Institutet in Sweden show that the scar tissue formed by stem cells after a spinal cord injury does not impair recovery; in fact, stem cell scarring confines the damage. The findings, ...

Recommended for you

Researchers grow retinal nerve cells in the lab

November 30, 2015

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. ...

Shining light on microbial growth and death inside our guts

November 30, 2015

For the first time, scientists can accurately measure population growth rates of the microbes that live inside mammalian gastrointestinal tracts, according to a new method reported in Nature Communications by a team at the ...

Functional human liver cells grown in the lab

November 26, 2015

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.